NEW YORK ( TheStreet) -- CHANGE IN RATINGS Agilent ( A) was downgraded at Goldman Sachs to neutral. $47 price target. Company lacks near-term catalysts, Goldman said. Allergan ( AGN) was downgraded at Wells Fargo to market perform. Restasis will likely soon face generic competition, Wells Fargo said. Bunge ( BG) was downgraded to hold at TheStreet Ratings. Coach ( COH) was downgraded at Lazard Capital Markets to neutral from buy. Company could face increased competition, Lazard Capital Markets said. DCIX) was downgraded to sell at TheStreet Ratings. Newell Rubbermaid ( NWL) was initiated with a neutral rating at Goldman Sachs. $27 price target. Valuation call, as the stock is up 70% from its 2011 lows, Goldman said. Waters ( WAT) was upgraded at Goldman Sachs to buy. $120 price target. Company is seeing better end-market demand, Goldman said.